Purchases and Sales Made in Q2 2021 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q2 2021. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 12, 2021
Q2 2021
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-15.7K- 29.96% |
$103K - $167K
|
36.7K
$0
|
|
Aug 16, 2021
Q2 2021
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-19.7K- 46.97% |
$130K - $210K
|
22.3K
$0
|
|
Aug 10, 2021
Q2 2021
|
Abrdn PLC
|
SELL
|
- |
-23.7KClosed |
$156K - $253K
|
0
$0
|
|
Aug 04, 2021
Q2 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-33.8K- 94.37% |
$222K - $360K
|
2.02K
$0
|
|
Aug 13, 2021
Q2 2021
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-47.6K- 70.21% |
$313K - $507K
|
20.2K
$0
|
|
Aug 16, 2021
Q2 2021
|
Atom Investors LP
Austin, TX |
SELL
|
- |
-54.8KClosed |
$360K - $584K
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-70.4KClosed |
$463K - $750K
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-78.8K- 37.74% |
$519K - $840K
|
130K
$0
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-98K- 40.35% |
$645K - $1.05M
|
145K
$0
|
|
Aug 16, 2021
Q2 2021
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-99.4K- 28.39% |
$654K - $1.06M
|
251K
$0
|
|
Aug 16, 2021
Q2 2021
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-555KClosed |
$3.65M - $5.92M
|
0
$0
|
|
Aug 16, 2021
Q2 2021
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-1.05MClosed |
$6.93M - $11.2M
|
0
$0
|
|
Aug 03, 2021
Q2 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-1.86M- 79.28% |
$12.2M - $19.8M
|
485K
$0
|
|
Aug 11, 2021
Q2 2021
|
Trv Gp Ii, LLC
Boston, MA |
SELL
|
- |
-2.05M- 31.58% |
$13.5M - $21.9M
|
4.45M
$0
|